Fuzhongren (Shanghai) Trading Co., Ltd. – Trademark Portfolio

Entity Type: 16

Fuzhongren (Shanghai) Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include NEOPELTA. The owner is based in Shanghai.

No. 1599 Pingzhuang West Road

Fengxian District

Shanghai 201400 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NEOPELTA
NEOPELTA
Registered 2021

Trademark Classifications

Fuzhongren (Shanghai) Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Fuzhongren (Shanghai) Trading Co., Ltd. have?

Fuzhongren (Shanghai) Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Fuzhongren (Shanghai) Trading Co., Ltd. file in?

Fuzhongren (Shanghai) Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Fuzhongren (Shanghai) Trading Co., Ltd.'s most well-known trademarks?

Fuzhongren (Shanghai) Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as NEOPELTA. These are among 1 currently registered trademark in the portfolio.

What is Fuzhongren (Shanghai) Trading Co., Ltd.'s trademark registration success rate?

Fuzhongren (Shanghai) Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.